|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, January 31, 2017 ) According to the report Nuclear Medicine Radiopharmaceuticals Market, published by Market Data Forecast, the global market is projected to reach USD 8.44 billion by 2020, at a CAGR of 13.4% from 2015 to 2020.
For full report refer to http://www.marketdataforecast.com/market-reports/global-nuclear-medicine-radiopharmaceuticals-market-130/
Nuclear medicine falls under the field of Molecular imaging, which involves usage of minute amount of radioactive material (radiopharmaceuticals) to diagnose and treat disease. Radiopharmaceuticals target a specific organ or site and emit the gamma radiations. These radiopharmaceuticals are administered inside the body by different routes of administration such as oral, inhalation or injection depending on the drug and targeted organ
Free sample for the report is available at http://www.marketdataforecast.com/market-reports/global-nuclear-medicine-radiopharmaceuticals-market-130/request-sample
Increasing prevalence of cancer and cardiac ailments, massive technological advancements, growing demand for SPECT and PET applications along with the increasing public awareness for healthcare are the major factors fuelling the market growth for Radiopharmaceuticals. Further, Integration of X ray tomography (CT) into SPECT has recently emerged as an excellent diagnostic tool in medical imaging and is considered to be a powerful factor for the growth of the market. However short half-life of radiopharmaceuticals and strict regulatory framework for pose a great threat to the market growth. Reimbursement also is a major factor restraining the growth of the market.
Avail discount at http://www.marketdataforecast.com/market-reports/global-nuclear-medicine-radiopharmaceuticals-market-130/request-discount
Global Nuclear Medicine Radiopharmaceuticals market is segmented by type and Application. By type it is further classified as diagnostic radioisotopes and therapeutic radioisotopes
Diagnostic Radioisotopes
SPECT
• Technetium-99m
• Thallium-201
• Gallium-67
• Iodine-23
• Others
PET
• Fluorine-18
• Rubidium-82
• Others
Therapeutic Radio Isotopes
Beta Emitters
• Iodine-131
• Yttrium-90
• Samarium-153
• Rhenium-186
• Lutetium-177
Alpha Emitters
• Radium-223
Brachytherapy
• Cesium-131
• Iodine-125
• Palladium-103
• Iridium-192
By Application
• Cardiology
• Lymphoma
• Thyroid
• Neurology
• Oncology
• Others
Enquire more about the report at http://www.marketdataforecast.com/market-reports/global-nuclear-medicine-radiopharmaceuticals-market-130/inquire
Some of the major players covered in the report are GE Healthcare, Hologic Inc., Medix Inc., Segami Corporation, Positron Corporation, Bracco Imaging S.p.A, Naviscan Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc. and IBA Molecular Imaging.
Buy now http://www.marketdataforecast.com/cart/buy-now/global-nuclear-medicine-radiopharmaceuticals-market-130
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Visit Marketdata Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
